These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33484921)

  • 1. Direct compression tablet formulation of celecoxib enabled with a pharmaceutical solvate.
    Wang K; Sun CC
    Int J Pharm; 2021 Mar; 596():120239. PubMed ID: 33484921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enabling direct compression tablet formulation of celecoxib by simultaneously eliminating punch sticking, improving manufacturability, and enhancing dissolution through co-processing with a mesoporous carrier.
    Paul S; Guo Y; Wang C; Dun J; Calvin Sun C
    Int J Pharm; 2023 Jun; 641():123041. PubMed ID: 37201765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enabling the Tablet Product Development of 5-Fluorocytosine by Conjugate Acid Base Cocrystals.
    Perumalla SR; Paul S; Sun CC
    J Pharm Sci; 2016 Jun; 105(6):1960-1966. PubMed ID: 27238493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the digital revolution on the future of pharmaceutical formulation science.
    Leuenberger H; Leuenberger MN
    Eur J Pharm Sci; 2016 May; 87():100-11. PubMed ID: 26876764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ; Aburub A; Sun CC
    J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the performance-controlling tablet disintegration mechanisms for direct compression formulations.
    Maclean N; Walsh E; Soundaranathan M; Khadra I; Mann J; Williams H; Markl D
    Int J Pharm; 2021 Apr; 599():120221. PubMed ID: 33540006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance.
    Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH
    Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tablet Formulation of a Synthesized Celecoxib Potassium Salt and Development of a Validated Method for Its Analysis.
    Abualhasan M; Zatar N; Shehab KA; Shraim N
    Curr Pharm Des; 2021; 27(25):2872-2880. PubMed ID: 32887541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
    Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
    AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
    J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
    Bejugam NK; Mutyam SK; Shankar GN
    Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficient development of a sildenafil orally disintegrating tablet using a material sparing and expedited approach.
    Wang C; Sun CC
    Int J Pharm; 2020 Nov; 589():119816. PubMed ID: 32877727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering.
    Wang C; Hu S; Sun CC
    Mol Pharm; 2017 Oct; 14(10):3399-3408. PubMed ID: 28825961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative correlation of the effect of process conditions on the capping tendencies of tablet formulations.
    Akseli I; Stecuła A; He X; Ladyzhynsky N
    J Pharm Sci; 2014 Jun; 103(6):1652-63. PubMed ID: 24668502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of piroxicam mini-tablets enabled by spherical cocrystallization.
    Chen H; Wang C; Liu S; Sun CC
    Int J Pharm; 2020 Nov; 590():119953. PubMed ID: 33039491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.